drugset / Trial / NCT04604587

MRI-visible Enlarged Perivascular Spaces and the Alteration of Lymphatic Drainage System in CAA

NCT04604587

Phase 3 Unknown 120 enrolled National Taiwan University Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

In this three-year proposal, we will explore the MRI-visible EPVS in CAA and investigate its pathophysiology using animal models. Our specific aims include: (1) Establish the relationship of MRI-visible enlarged perivascular space and CAA, (2) Determine whether vascular amyloid clearance in CAA is associated with lymphatic drainage system, (3) Establish longitudinal data for MRI-visible enlarged perivascular space and cerebral amyloid angiopathy progression.

Timeline

Start
2020-10-08
Primary completion
2023-07-31
Completion
2023-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 11C-PiB Diagnostic / imaging agent 10 unknown
Subject florbetapir F 18 Diagnostic / imaging agent 10 unknown